Explore the words cloud of the INCENTIVE project. It provides you a very rough idea of what is the project "INCENTIVE" about.
The following table provides information about the project.
HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH
|Coordinator Country||Germany [DE]|
|Total cost||19˙965˙992 €|
|EC max contribution||9˙974˙293 € (50%)|
1. H2020-EU.3.1.2. (Preventing disease)
|Duration (year-month-day)||from 2020-04-01 to 2025-03-31|
Take a look of project's partnership.
|1||HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH||DE (BRAUNSCHWEIG)||coordinator||2˙537˙797.00|
|2||ACADEMISCH ZIEKENHUIS LEIDEN||NL (LEIDEN)||participant||1˙003˙785.00|
|3||UNIVERSITEIT ANTWERPEN||BE (ANTWERPEN)||participant||919˙943.00|
|4||STICHTING HUMAN VACCINES PROJECT EUROPE||NL (CASTRICUM)||participant||794˙312.00|
|5||HUMAN VACCINES PROJECT, INC||US (WILMINGTON NEW CASTLE)||participant||760˙705.00|
|6||UNIVERSITE LIBRE DE BRUXELLES||BE (BRUXELLES)||participant||614˙963.00|
|7||UGA RESEARCH FOUNDATION INC NON PROFIT CORP||US (ATHENS)||participant||586˙990.00|
|8||UNIVERSITETET I BERGEN||NO (BERGEN)||participant||567˙296.00|
|9||BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE||FR (LYON)||participant||531˙858.00|
|10||INSTITUT PASTEUR||FR (PARIS CEDEX 15)||participant||441˙260.00|
|11||ASA SPEZIALENZYME GMBH||DE (WOLFENBUTTEL)||participant||387˙750.00|
|12||FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA||ES (BARCELONA)||participant||383˙670.00|
|13||UNIVERSITETET I OSLO||NO (OSLO)||participant||307˙086.00|
|14||EUROVACC FOUNDATION||CH (LAUSANNE)||participant||136˙875.00|
|15||INDIAN INSTITUTE OF TECHNOLOGY MADRAS (IITM)||IN (Chennai)||participant||0.00|
|16||NATIONAL INSTITUTE OF IMMUNOLOGY SOCIETY||IN (NEW DELHI)||participant||0.00|
|17||PUBLIC HEALTH FOUNDATION OF INDIA||IN (NEW DELHI)||participant||0.00|
|18||SETH G S M COLLEGE AND K E M HOSPITAL DIAMOND JUBILEE SOCIETY||IN (MUMBAI)||participant||0.00|
|19||TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE||IN (FARIDABAD)||participant||0.00|
The highly integrated INCENTIVE consortium represents true partnership between Indian and European/US groups that addresses the global health and economic challenge posed by influenza infections, to reduce the worldwide burden resulting from outbreaks. INCENTIVE’s strategic goals are to provide seminal knowledge on the underlying mechanisms of poor responsiveness to influenza vaccines in vulnerable individuals and advance the development of two next generation universal influenza vaccines. This is achieved by pursing the following specific objectives: 1) address the current knowledge gap by performing comprehensive immunome profiling of responders and non-responders to licensed influenza vaccines in infants, children, adults and elderly in parallel phase IV trials in Europe and India to identify the underlying mechanisms of vaccine responsiveness in different vulnerable populations and ethnical groups; 2) advance the development of two next generation universal vaccines, including an antigen presenting cell-targeted nucleic acid vaccine up to proof-of-concept for vaccine efficacy in non-human primates, and a computationally-derived second generation COBRA (Computationally-Optimized Broadly-Reactive Antigens) vaccine up to clinical development, comprising a phase I trial in Europe, a phase II trial in India and efficacy studies using an influenza controlled human challenge model; 3) identify predictive biomarkers of responsiveness to vaccination to develop new diagnostics; 4) implement comprehensive technology transfer and harmonization activities for immunological analysis and data integration; and 5) perform a health systems and investment analysis, and discrete choice experiments to assess the suitability of the developed technologies for low- and middle-income countries and to identify potential downstream constraints that might affect uptake by health care systems.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INCENTIVE" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "INCENTIVE" are provided by the European Opendata Portal: CORDIS opendata.
Developing a diverse portfolio of vaccine candidates for Rift Valley Fever, Chikungunya and EbolaRead More
European platforM to PromOte Wellbeing and HEalth in the woRkplaceRead More
Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response.Read More